— Know what they know.
Not Investment Advice
Also trades as: NUVB-WT (NYSE) · $vol 0M

NUVB NYSE

Nuvation Bio Inc.
1W: +1.5% 1M: -6.5% 3M: -11.9% YTD: -44.2% 1Y: +120.7% 3Y: +199.4% 5Y: -56.5%
$4.72
-0.07 (-1.46%)
 
Weekly Expected Move ±8.7%
$4 $4 $4 $5 $5
NYSE · Healthcare · Biotechnology · Alpha Radar Neutral · Power 40 · $1.6B mcap · 238M float · 1.86% daily turnover · Short 64% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$63M +699.0% ▲
Gross Profit
$54M +6750.3% ▲
Operating Income
-$213M +64.0% ▲
Net Income
-$205M +64.0% ▲
EPS (Diluted)
$-0.60 +71.6% ▲
EBITDA
-$191M +66.3% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$8M$63M
YoY Growth+0.0%+0.0%+0.0%+0.0%+699.0%
Cost of Revenue$0$0$0$7M$8M
Gross Profit$0$0$0$795K$54M
Gross Margin10.1%86.6%
R&D Expenses$69M$88M$71M$524M$115M
SG&A Expenses$24M$32M$29M$69M$152M
Operating Expenses$93M$120M$100M$593M$268M
Operating Income-$93M-$120M-$100M-$593M-$213M
Operating Margin-7527.3%-338.7%
Interest Expense$0$0$0$341K$14M
Income Before Tax-$87M-$104M-$76M-$568M-$205M
Tax Expense$0$0$0$0$0
Net Income-$87M-$104M-$76M-$568M-$205M
Net Margin-7213.8%-325.3%
EPS (Diluted)$-0.44$-0.48$-0.35$-2.11$-0.60
EBITDA-$93M-$120M-$76M-$567M-$191M
Shares Outstanding198M217M219M269M342M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms